Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

25.45
+0.70002.83%
Post-market: 25.450.00000.00%16:59 EDT
Volume:296.73K
Turnover:7.49M
Market Cap:699.90M
PE:-9.47
High:25.77
Open:25.17
Low:24.78
Close:24.75
Loading ...

Press Release: Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
11 Mar

Mineralys Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
11 Mar

Beam Therapeutics Raised to Sector Outperform From Sector Perform by Scotiabank

Dow Jones
·
11 Mar

Checkpoint Therapeutics Cut to Hold From Buy by Lake Street

Dow Jones
·
11 Mar

Beam Therapeutics Raised to Buy From Hold by Jones Trading

Dow Jones
·
11 Mar

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate

Benzinga
·
11 Mar

JonesResearch upgrades Beam Therapeutics to Buy on de-risking data

TIPRANKS
·
11 Mar

Beam Therapeutics upgraded to Buy from Hold at JonesResearch

TIPRANKS
·
11 Mar

HC Wainwright Adjusts Trevi Therapeutics Price Target to $12.50 From $7.50, Maintains Buy Rating

MT Newswires Live
·
11 Mar

Beam Therapeutics Shares Drop After $500M Offering Prices

Dow Jones
·
11 Mar

Trevi Therapeutics price target raised to $12.50 from $7.50 at H.C. Wainwright

TIPRANKS
·
11 Mar

Correction to Checkpoint Therapeutics Headline

Dow Jones
·
10 Mar

Scotiabank Upgrades Beam Therapeutics to Sector Outperform From Sector Perform, $40 Price Target

MT Newswires Live
·
10 Mar

Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target

MT Newswires Live
·
10 Mar

Leerink Adjusts Price Target on Trevi Therapeutics to $11 From $7, Maintains Outperform Rating

MT Newswires Live
·
10 Mar

Beam Therapeutics upgraded to Outperform from Sector Perform at Scotiabank

TIPRANKS
·
10 Mar